The Enterprise Value as of December 2025 (TTM) for Soleno Therapeutics, Inc. (SLNO) is 2.59B

According to Soleno Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.59B. This represents a change of -19.06% compared to the average of 3.19B of the last 4 quarters.

Soleno Therapeutics, Inc. (SLNO) Historical Enterprise Value (quarterly & annually)

How has SLNO Enterprise Value performed in the past?

The mean historical Enterprise Value of Soleno Therapeutics, Inc. over the last ten years is 387.51M. The current 2.59B Enterprise Value has changed 66.62% with respect to the historical average. Over the past ten years (40 quarters), SLNO's Enterprise Value was at its highest in in the June 2025 quarter at 4.21B. The Enterprise Value was at its lowest in in the September 2022 quarter at 59.12M.

Soleno Therapeutics, Inc. (SLNO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Soleno Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Soleno Therapeutics, Inc. (SLNO) Average Enterprise Value

How has SLNO Enterprise Value performed in the past?

The current Enterprise Value of Soleno Therapeutics, Inc. (SLNO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Soleno Therapeutics, Inc. (SLNO) Enterprise Value vs. Peers

How is SLNO’s Enterprise Value compared to its peers?

Soleno Therapeutics, Inc.’s Enterprise Value is less than Praxis Precision Medicines, Inc. (3.86B), greater than Dyne Therapeutics, Inc. (2.49B), less than ASCENTAGE PHARMA GROUP INTERNATIONAL (20.23B), less than Apogee Therapeutics, Inc. (4.04B), less than Centessa Pharmaceuticals plc (4.05B), less than Xenon Pharmaceuticals Inc. (3.32B), less than Ultragenyx Pharmaceutical Inc. (3.33B), less than Mirum Pharmaceuticals, Inc. (3.57B), less than Celcuity Inc. (5.14B), less than Viking Therapeutics, Inc. (4.26B),

Build a custom stock screener for Soleno Therapeutics, Inc. (SLNO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Soleno Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Soleno Therapeutics, Inc. (SLNO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Soleno Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.